Your browser doesn't support javascript.
loading
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.
Luukkonen, Panu K; Zhou, You; Nidhina Haridas, P A; Dwivedi, Om P; Hyötyläinen, Tuulia; Ali, Ashfaq; Juuti, Anne; Leivonen, Marja; Tukiainen, Taru; Ahonen, Linda; Scott, Emma; Palmer, Jeremy M; Arola, Johanna; Orho-Melander, Marju; Vikman, Petter; Anstee, Quentin M; Olkkonen, Vesa M; Oresic, Matej; Groop, Leif; Yki-Järvinen, Hannele.
Afiliación
  • Luukkonen PK; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland. Electronic address: panu.luukkonen@fimnet.fi.
  • Zhou Y; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Systems Immunity University Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Nidhina Haridas PA; Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Dwivedi OP; Institute for Molecular Medicine Finland, Helsinki, Finland.
  • Hyötyläinen T; Department of Chemistry, Örebro University, Örebro, Sweden.
  • Ali A; Steno Diabetes Center, Gentofte, Denmark.
  • Juuti A; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Leivonen M; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tukiainen T; Institute for Molecular Medicine Finland, Helsinki, Finland.
  • Ahonen L; Steno Diabetes Center, Gentofte, Denmark.
  • Scott E; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Palmer JM; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Arola J; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Orho-Melander M; Lund University, Malmö, Sweden.
  • Vikman P; Lund University, Malmö, Sweden.
  • Anstee QM; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Olkkonen VM; Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Oresic M; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Groop L; Institute for Molecular Medicine Finland, Helsinki, Finland; Lund University, Malmö, Sweden.
  • Yki-Järvinen H; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland.
J Hepatol ; 67(1): 128-136, 2017 07.
Article en En | MEDLINE | ID: mdl-28235613
BACKGROUND: Carriers of the transmembrane 6 superfamily member 2 E167K gene variant (TM6SF2EK/KK) have decreased expression of the TM6SF2 gene and increased risk of NAFLD and NASH. Unlike common 'obese/metabolic' NAFLD, these subjects lack hypertriglyceridemia and have lower risk of cardiovascular disease. In animals, phosphatidylcholine (PC) deficiency results in a similar phenotype. PCs surround the core of VLDL consisting of triglycerides (TGs) and cholesteryl-esters (CEs). We determined the effect of the TM6SF2 E167K on these lipids in the human liver and serum and on hepatic gene expression and studied the effect of TM6SF2 knockdown on hepatocyte handling of these lipids. METHODS: Liver biopsies were taken from subjects characterized with respect to the TM6SF2 genotype, serum and liver lipidome, gene expression and histology. In vitro, after TM6SF2 knockdown in HuH-7 cells, we compared incorporation of different fatty acids into TGs, CEs, and PCs. RESULTS: The TM6SF2EK/KK and TM6SF2EE groups had similar age, gender, BMI and HOMA-IR. Liver TGs and CEs were higher and liver PCs lower in the TM6SF2EK/KK than the TM6SF2EE group (p<0.05). Polyunsaturated fatty acids (PUFA) were deficient in liver and serum TGs and liver PCs but hepatic free fatty acids were relatively enriched in PUFA (p<0.05). Incorporation of PUFA into TGs and PCs in TM6SF2 knockdown hepatocytes was decreased (p<0.05). Hepatic expression of TM6SF2 was decreased in variant carriers, and was co-expressed with genes regulated by PUFAs. CONCLUSIONS: Hepatic lipid synthesis from PUFAs is impaired and could contribute to deficiency in PCs and increased intrahepatic TG in TM6SF2 E167K variant carriers.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Grasos Insaturados / Enfermedad del Hígado Graso no Alcohólico / Lípidos / Hígado / Proteínas de la Membrana Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácidos Grasos Insaturados / Enfermedad del Hígado Graso no Alcohólico / Lípidos / Hígado / Proteínas de la Membrana Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos